Addex Therapeutics Ltd. Rings the Closing Bell

ABOUT THIS EVENT

Addex Therapeutics Ltd. (Nasdaq: ADXN), a leading allosteric modulation-based drug discovery and development company, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Tim Dyer, CEO, rang the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore